首页> 美国卫生研究院文献>British Journal of Cancer >Immunological comparison of carcinoembryonic antigen (CEA) extracted from tumours of various organs: their use in radioimmunological CEA determinations.
【2h】

Immunological comparison of carcinoembryonic antigen (CEA) extracted from tumours of various organs: their use in radioimmunological CEA determinations.

机译:从各器官肿瘤中提取的癌胚抗原(CEA)的免疫学比较:它们在放射免疫学CEA测定中的用途。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

CEA was extracted by the perchloric acid method from primary adenocarcinomas of the colon and the ovary, from ascitic and pleural fluids from patients with pancreatic, lung and breast cancer, and from the cyst fluid of a benign ovarian cystadenoma. Further purification included gel filtration and affinity chromatography. Antisera against CEA from colon, breast, ovary, lung and pancreatic cancer were produced in rabbits. In double diffusion experiments, all these CEA samples showed a reaction of complete immunological identity with all the anti-CEA sera, whatever their origin. CEA from colon, breast, pancreas and ovary were labelled with 125I and used in radioimmunological experiments. In a radioimmunological system where the tracer and the antiserum were constant, all the CEA used as standards gave parallel inhibition curves, having nearly identical slopes. This was another criterion of immunological identity. Sera of numerous cancer patients were assayed in several RIA systems, one of them being the classical system with colonic CEA as tracer and anti-colonic CEA as antiserum, the others being "organ specific" systems. The values obtained in these assays were found to be highly correlated: the rank coefficient of correlation between colonic and breast cancer RIA systems was rs = 0.96, that between colonic and ovarian RIA systems, 0.92, that between colonic and pancreatic RIA systems, 0.97 and that between colonic and lung RIA systems 0.96. It is thus concluded that by use of different organ-derived CEA preparations and their corresponding polyclonal antisera, no significative differences in serum CEA levels may be expected. No evidence of organ specificity of serum CEA was found.
机译:通过高氯酸法从结肠和卵巢的原发性腺癌,胰腺癌,肺癌和乳腺癌患者的腹水和胸膜液以及卵巢良性膀胱腺瘤的囊液中提取CEA。进一步的纯化包括凝胶过滤和亲和色谱。在兔中产生了来自结肠癌,乳腺癌,卵巢癌,肺癌和胰腺癌的针对CEA的抗血清。在双扩散实验中,所有这些CEA样品均与所有抗CEA血清显示完全免疫同一性的反应,无论其来源如何。来自结肠,乳房,胰腺和卵巢的CEA用125 I标记,并用于放射免疫实验。在示踪剂和抗血清恒定的放射免疫系统中,所有用作标准品的CEA均具有平行的抑制曲线,其斜率几乎相同。这是免疫同一性的另一个标准。在多个RIA系统中测定了许多癌症患者的血清,其中一个是经典系统,其中结肠CEA作为示踪剂,抗结肠癌CEA作为抗血清,其他则是“器官特异性”系统。发现在这些测定中获得的值高度相关:结肠癌和乳腺癌RIA系统之间的相关秩系数rs = 0.96,结肠癌和卵巢RIA系统之间的相关系数为0.92,结肠癌和胰腺RIA系统之间的相关系数为0.97和结肠和肺RIA系统之间的差异为0.96。因此得出的结论是,通过使用不同的器官来源的CEA制剂及其相应的多克隆抗血清,血清CEA水平不会有显着差异。没有发现血清CEA的器官特异性的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号